Therapeutic Solutions International, Inc.
  • Home
    • Management
    • Scientific Advisory Board
  • Press
  • Patents
  • Pipeline
  • Investors
    • OTC Markets
    • SEC Edgar
    • Placement Agent
    • Forum
  • Subs
    • Allogen Biologics
    • Breathe Biologics
    • Campbell Neurosciences
    • CTE Biologics
    • Res Nova Bio
    • VasoSome Vascular
    • Veltmeyer Institute
Select Page

 Therapeutic Solutions International, Inc. (TSOI)

Activating one’s immune system is now an accepted method to treat certain cancers, reduce recovery time from viral or bacterial infections, and prevent illness.

 

Recent News

05-25-2023 Therapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells
05-22-2023 Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses
05-15-2023 Therapeutic Solutions International Spin-Off Res Nova Bio Partners with Cure Stat Rx to Manufacture First in Class Breast Cancer Immunotherapy Product FloraStilbene™

  • Facebook
  • Twitter
  • Instagram
  • RSS